657 related articles for article (PubMed ID: 29610956)
21. Assessment of treatment response in cardiac sarcoidosis based on myocardial
Frischknecht L; Schaab J; Schmauch E; Yalamanoglu A; Arnold DD; Schwaiger J; Gruner C; Buechel RR; Franzen DP; Kolios AGA; Nilsson J
Front Immunol; 2023; 14():1286684. PubMed ID: 38077350
[TBL] [Abstract][Full Text] [Related]
22. Prospective Evaluation of 18F-Fluorodeoxyglucose Uptake in Postischemic Myocardium by Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging as a Prognostic Marker of Functional Outcome.
Rischpler C; Dirschinger RJ; Nekolla SG; Kossmann H; Nicolosi S; Hanus F; van Marwick S; Kunze KP; Meinicke A; Götze K; Kastrati A; Langwieser N; Ibrahim T; Nahrendorf M; Schwaiger M; Laugwitz KL
Circ Cardiovasc Imaging; 2016 Apr; 9(4):e004316. PubMed ID: 27056601
[TBL] [Abstract][Full Text] [Related]
23. Rituximab for the Treatment of Refractory Cardiac Sarcoidosis: A Single-Center Experience.
Elwazir M; Krause ML; Bois JP; Christopoulos G; Kendi AT; Cooper JLT; Jouni H; Abouezzeddine OF; Chareonthaitawee P; Abdelshafee M; Amin S
J Card Fail; 2022 Feb; 28(2):247-258. PubMed ID: 34320381
[TBL] [Abstract][Full Text] [Related]
24. The response of FDG uptake to immunosuppressive treatment on FDG PET/CT imaging for cardiac sarcoidosis.
Ahmadian A; Pawar S; Govender P; Berman J; Ruberg FL; Miller EJ
J Nucl Cardiol; 2017 Apr; 24(2):413-424. PubMed ID: 27457527
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic accuracy and prognostic value of simultaneous hybrid 18F-fluorodeoxyglucose positron emission tomography/magnetic resonance imaging in cardiac sarcoidosis.
Wicks EC; Menezes LJ; Barnes A; Mohiddin SA; Sekhri N; Porter JC; Booth HL; Garrett E; Patel RS; Pavlou M; Groves AM; Elliott PM
Eur Heart J Cardiovasc Imaging; 2018 Jul; 19(7):757-767. PubMed ID: 29319785
[TBL] [Abstract][Full Text] [Related]
26. Case of isolated cardiac sarcoidosis diagnosed by newly developed abnormal uptake during serial follow-up fluorine-18 fluorodeoxyglucose positron emission tomography.
Maeda D; Kanzaki Y; Fujita S; Inuyama M; Takashima S; Miyamura M; Terasaki F; Hoshiga M
ESC Heart Fail; 2019 Aug; 6(4):889-893. PubMed ID: 31264810
[TBL] [Abstract][Full Text] [Related]
27. Heterogeneous myocardial FDG uptake and the disease activity in cardiac sarcoidosis.
Tahara N; Tahara A; Nitta Y; Kodama N; Mizoguchi M; Kaida H; Baba K; Ishibashi M; Hayabuchi N; Narula J; Imaizumi T
JACC Cardiovasc Imaging; 2010 Dec; 3(12):1219-28. PubMed ID: 21163450
[TBL] [Abstract][Full Text] [Related]
28. Atrioventricular block as the initial manifestation of cardiac sarcoidosis in middle-aged adults.
Nery PB; Beanlands RS; Nair GM; Green M; Yang J; McArdle BA; Davis D; Ohira H; Gollob MH; Leung E; Healey JS; Birnie DH
J Cardiovasc Electrophysiol; 2014 Aug; 25(8):875-881. PubMed ID: 24602015
[TBL] [Abstract][Full Text] [Related]
29. Incremental Prognostic Value of Global Longitudinal Strain and 18F-Fludeoxyglucose Positron Emission Tomography in Patients With Systemic Sarcoidosis.
Sperry BW; Ibrahim A; Negishi K; Negishi T; Patel P; Popović ZB; Culver D; Brunken R; Marwick TH; Tamarappoo B
Am J Cardiol; 2017 May; 119(10):1663-1669. PubMed ID: 28343598
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic values of delayed additional FDG PET/CT scan in the evaluation of cardiac sarcoidosis.
Manabe O; Takahashi K; Kawakami H; Ohtsuka A; Aikawa T; Maki H; Ibe T; Fujita H; Oyama-Manabe N
Ann Nucl Med; 2023 Oct; 37(10):535-540. PubMed ID: 37418117
[TBL] [Abstract][Full Text] [Related]
31.
Furuya S; Naya M; Manabe O; Hirata K; Ohira H; Aikawa T; Koyanagawa K; Magota K; Tsujino I; Anzai T; Kuge Y; Oyama-Manabe N; Kudo K; Shiga T; Tamaki N
J Nucl Cardiol; 2021 Oct; 28(5):2141-2148. PubMed ID: 31820409
[TBL] [Abstract][Full Text] [Related]
32. Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis.
Trivieri MG; Robson PM; Vergani V; LaRocca G; Romero-Daza AM; Abgral R; Devesa A; Azoulay LD; Karakatsanis NA; Parikh A; Panagiota C; Palmisano A; DePalo L; Chang HL; Rothstein JH; Fayad RA; Miller MA; Fuster V; Narula J; Dweck MR; Morgenthau A; Jacobi A; Padilla M; Kovacic JC; Fayad ZA
JACC Cardiovasc Imaging; 2024 Apr; 17(4):411-424. PubMed ID: 38300202
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up of patients with cardiac sarcoidosis and implantable cardioverter-defibrillators.
Betensky BP; Tschabrunn CM; Zado ES; Goldberg LR; Marchlinski FE; Garcia FC; Cooper JM
Heart Rhythm; 2012 Jun; 9(6):884-91. PubMed ID: 22338670
[TBL] [Abstract][Full Text] [Related]
34. The prognostic value of positron emission tomography in the evaluation of suspected cardiac sarcoidosis.
Patel VN; Pieper JA; Poitrasson-Rivière A; Kopin D; Cascino T; Aaronson K; Murthy VL; Koelling T
J Nucl Cardiol; 2022 Oct; 29(5):2460-2470. PubMed ID: 34505261
[TBL] [Abstract][Full Text] [Related]
35. Quantitative analysis of myocardial 18F-fluorodeoxyglucose uptake by PET/CT for detection of cardiac sarcoidosis.
Yokoyama R; Miyagawa M; Okayama H; Inoue T; Miki H; Ogimoto A; Higaki J; Mochizuki T
Int J Cardiol; 2015 Sep; 195():180-7. PubMed ID: 26043154
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis.
Flores RJ; Flaherty KR; Jin Z; Bokhari S
J Nucl Cardiol; 2020 Dec; 27(6):2003-2010. PubMed ID: 30421379
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of fluorine-18 fluoro-2-deoxyglucose positron emission computed tomography in patients with unexplained atrioventricular block.
Danwade TA; Devidutta S; Shelke AB; Saggu DK; Yalagudri SD; Sridevi C; Reddy NK; Narasimhan C
Heart Rhythm; 2018 Feb; 15(2):234-239. PubMed ID: 29061522
[TBL] [Abstract][Full Text] [Related]
38. Visual findings of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with cardiac sarcoidosis.
Ito K; Okazaki O; Morooka M; Kubota K; Minamimoto R; Hiroe M
Intern Med; 2014; 53(18):2041-9. PubMed ID: 25224185
[TBL] [Abstract][Full Text] [Related]
39. Identification of cardiac sarcoidosis with (13)N-NH(3)/(18)F-FDG PET.
Yamagishi H; Shirai N; Takagi M; Yoshiyama M; Akioka K; Takeuchi K; Yoshikawa J
J Nucl Med; 2003 Jul; 44(7):1030-6. PubMed ID: 12843216
[TBL] [Abstract][Full Text] [Related]
40. Prednisone vs methotrexate in treatment naïve cardiac sarcoidosis.
Vis R; Mathijssen H; Keijsers RGM; van de Garde EMW; Veltkamp M; Akdim F; Post MC; Grutters JC
J Nucl Cardiol; 2023 Aug; 30(4):1543-1553. PubMed ID: 36640249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
